| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |


From the Center for Neurovirology and Cancer Biology,*Temple University, Philadelphia, Pennsylvania; the Department of Pathology and Laboratory Medicine,
Drexel University, Philadelphia, Pennsylvania; and the Mount Sinai School of Medicine,
New York, New York
This study was performed to quantitate and characterize the mononuclear phagocytes (MPs) in human immunodeficiency virus encephalopathy (HIVE) by immunohistochemistry in an effort to gain insights into potential mechanisms of central nervous system (CNS) accumulation. Single- and double-labeled studies using antibodies against CD14, CD16, CD68, proliferating cell nuclear antigen (PCNA), Ki-67, von Willebrand factor, and HIV-1 p24 were performed using brain tissue from patients with HIVE, HIV-1 infection without encephalitis, and seronegative controls. A substantial increase in MPs was observed in CNS tissue from patients with HIVE, relative to seronegative controls and patients with acquired immune deficiency syndrome but without encephalitis, as determined by CD68 and CD16 immunohistochemistry. A large proportion of CD16+ MPs in HIVE CNS tissue were PCNA+, but do not appear to be proliferating, based on limited Ki-67 positivity. Although virtually all cells positive for HIV-1 p24 were PCNA+, there were many PCNA+ cells where HIV-1 p24 expression was not detected. PCNA positivity was also observed in some endothelial cells and ependymal cells in HIVE CNS. Our results would support a role for HIV-1-induced alterations in MP trafficking and homeostasis in the pathogenesis of HIVE.
This article has been cited by other articles:
![]() |
W.-K. Kim, X. Alvarez, J. Fisher, B. Bronfin, S. Westmoreland, J. McLaurin, and K. Williams CD163 Identifies Perivascular Macrophages in Normal and Viral Encephalitic Brains and Potential Precursors to Perivascular Macrophages in Blood Am. J. Pathol., March 1, 2006; 168(3): 822 - 834. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. McCrossan, M. Marsden, F. W. Carnie, S. Minnis, B. Hansoti, I. C. Anthony, R. P. Brettle, J. E. Bell, and P. Simmonds An immune control model for viral replication in the CNS during presymptomatic HIV infection Brain, February 1, 2006; 129(2): 503 - 516. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. O'Donnell, A. Agrawal, K. L. Jordan-Sciutto, M. A. Dichter, D. R. Lynch, and D. L. Kolson Human Immunodeficiency Virus (HIV)-Induced Neurotoxicity: Roles for the NMDA Receptor Subtypes J. Neurosci., January 18, 2006; 26(3): 981 - 990. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Pugliese, V. Vidotto, T. Beltramo, and D. Torre Phagocytic Activity in Human Immunodeficiency Virus Type 1 Infection Clin. Vaccine Immunol., August 1, 2005; 12(8): 889 - 895. [Full Text] [PDF] |
||||
![]() |
H.-S. Suh, M.-O. Kim, and S. C. Lee Inhibition of Granulocyte-Macrophage Colony-Stimulating Factor Signaling and Microglial Proliferation by Anti-CD45RO: Role of Hck Tyrosine Kinase and Phosphatidylinositol 3-Kinase/Akt J. Immunol., March 1, 2005; 174(5): 2712 - 2719. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |